483
Xinxiang Tuoxin Pharmaceutical Co. LtdFDA 483 - Xinxiang Tuoxin Pharmaceutical Co. Ltd - June 06, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Xinxiang Tuoxin Pharmaceutical Co., Ltd in Xinxiang, China, revealed significant deficiencies across multiple areas of their operations. The firm failed to adequately establish impurity profiles, validate analytical methods, ensure data integrity in computerized systems, and properly handle product quality complaints. These observations indicate a need for improved quality control and adherence to good manufacturing practices.
Open in Dashboard
ID · 8eff03f5-2bc3-4e9a-95ce-4be2647445c7